School Of Medicine Basic Sciences
-
Alum Answers with Kavya Sharman
Kavya Sharman, BS’16, PhD’22, channeled dual expertise in science and business into launching Phase Capital, a Nashville-based venture capital firm focused on tech bio. Today, she supports founders working to transform scientific discoveries into scalable applications across the U.S., all while maintaining close ties to her Vanderbilt alma mater and home. Read MoreJan. 13, 2026
-
School of Medicine Basic Sciences Staff Spotlight: RC Stabile
The School of Medicine Basic Sciences is a remarkable community dedicated to advancing the study of human biology, health, and disease. In addition to the award-winning faculty, postdocs, and students who are at the forefront of our cutting-edge research, a large part of our school’s success can be attributed to… Read MoreDec. 23, 2025
-
Prominent molecular biologist André Nussenzweig delivers Apex Lecture on genome stability in both mitotic and post-mitotic cells
National Cancer Institute molecular biologist André Nussenzweig delivered a School of Medicine Basic Sciences Apex Lecture on Dec. 15 about genome stability in mitotic and post-mitotic cells. Read MoreDec. 22, 2025
-
Fall 2025 Class Notes
Our School of Medicine Basic Sciences alums go far and wide. Check out the latest accomplishments from some of our alums! If you're an alum, let us know of any recent developments in your life. Read MoreDec. 20, 2025
-
School of Medicine Basic Sciences: 2025 in review
As 2025 draws to a close, we reflect on the achievements and contributions to science made by the School of Medicine Basic Sciences community over the past year. SOMBS facilitates outstanding fundamental science research across four departments, two institutes, 10 centers, and 18 core facilities. The work of our faculty,… Read MoreDec. 17, 2025
-
Collins named Destination Biochemistry Stanley Cohen Postdoctoral Scholar
Hannah Collins was named the 2025 Destination Biochemistry Stanley Cohen Postdoctoral Scholar in recognition of her exceptional training, innovative research on microglial signaling, and strong potential as a future scientific leader. Joining Bruce Carter’s lab, she brings significant expertise and new perspectives to studies of the Jedi receptor in microglial function. Read MoreDec. 16, 2025
-
Osheroff lab provides mechanistic data in successful FDA application for new gonorrhea treatment
The U.S. Food and Drug Administration has approved the use of the new antibiotic gepotidacin for use against uncomplicated gonorrhea. The biochemistry lab of Neil Osheroff provided all mechanism of action data in the FDA application. Read MoreDec. 11, 2025
-
National Cancer Institute Laboratory of Genome Integrity Chief André Nussenzweig to deliver Apex Lecture on Dec. 15
Laboratory of Genome Integrity chief André Nussenzweig will present the Vanderbilt School of Medicine Basic Sciences Apex Lecture on Monday, Dec. 25, 2025. Read MoreDec. 2, 2025
-
Erin Calipari receives ACNP’s Daniel H. Efron Research Award
With novel insights in understanding and treating substance use disorder that have redirected neuropsychopharmacological dogma, Erin Calipari receives award from the American College of Neuropsychopharmacology. Read MoreDec. 1, 2025
-
Trainee Tribute: Katherine Clowes Moster
Meet Katherine Clowes Moster, a trainee in the lab of Chuck Sanders in the Department of Biochemistry. Read MoreDec. 1, 2025